ClearView Tele-Ophthalmology Platform
Business Overview
Overview
ClearView is a SaaS platform designed to bridge the gap in eye care accessibility by connecting patients and ophthalmologists for remote diagnostics and prescription fulfillment. The platform leverages cutting-edge AI to support clinical-grade vision screening and diagnostic triage, making eye health management feasible for underserved and remote populations.
Key Features
- AI-assisted vision screening: Users can conduct basic eye exams and upload retinal images via their smartphones or designated partner clinics, which AI then analyzes for early signs of serious conditions.
- Remote consultation: Patients are matched with certified ophthalmologists for secure video calls and messaging, enabling real-time expert opinions, review of AI results, and comprehensive care.
- E-prescription fulfillment: Following diagnosis, digital prescriptions are sent directly to partnered local or online pharmacies, facilitating seamless access to treatment or corrective eyewear.
User Experience
ClearView delivers a streamlined journey: patients create an account, conduct a quick self-screening with guided instructions, connect with a professional for diagnosis, and instantly receive prescriptions and follow-up plans—all from their homes. Accessibility features and elderly-friendly interfaces enable a broad demographic reach.
Market Opportunity
The growing chart of global vision impairment, a rising elderly population, and the need for convenient healthcare are fueling demand for telehealth. ClearView addresses significant gaps in rural or resource-limited areas where specialist access is scarce. The SaaS model supports scalability across B2B partnerships with clinics, pharmacies, and employers, while also enabling B2C direct-to-patient engagement.
TAM, Trends & Demand
Global Market Size: The tele-ophthalmology market is projected to surpass $2 billion by 2028, with annualized growth exceeding 20% due to the surge in chronic conditions and digital health adoption.
AI diagnostics are redefining screening accuracy and speed, particularly in diabetic retinopathy, glaucoma, and macular degeneration—conditions that are often underdiagnosed due to specialist shortages in remote and aging communities.
Key adoption drivers include improved cost-efficacy over physical clinics, population aging, shifting to digital health, and consumer expectations for end-to-end seamless care experiences.
Barriers: Regulatory compliance, digital literacy among seniors, and secure handling of health data. However, strong interest from insurers and pharmacies in remote fulfillment is accelerating market integration.
Ready to Start Your ClearView Tele-Ophthalmology Platform Business?
Get a comprehensive business plan with financial projections, marketing strategies, and step-by-step guidance.